Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-23-134428
Filing Date
2023-05-03
Accepted
2023-05-03 16:20:14
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d488310d424b5.htm 424B5 471744
2 GRAPHIC g488310g22s22.jpg GRAPHIC 62223
3 GRAPHIC g488310g25b45.jpg GRAPHIC 58583
  Complete submission text file 0001193125-23-134428.txt   628005
Mailing Address 18575 JAMBOREE ROAD SUITE 275-S IRVINE CA 92612
Business Address 18575 JAMBOREE ROAD SUITE 275-S IRVINE CA 92612 (858) 283-0280
Reneo Pharmaceuticals, Inc. (Filer) CIK: 0001637715 (see all company filings)

IRS No.: 472309515 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-264616 | Film No.: 23884308
SIC: 2834 Pharmaceutical Preparations